Company
Vektor Medical
Arrhythmia analysis from just an ECG
Also known as Vektor Medical, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- hospitals and health systems
- Legal name
- Vektor Medical, Inc.
- vektormedical.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are advancing care for arrhythmia patients by unlocking insights contained in a standard ECG. vMap is an arrhythmia analysis tool developed with Al, created to improve cardiac ablation outcomes, optimize workflows and increase procedural efficiency.
Funding snapshot
- Total raised
- $32.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series A, $16M2024-02-05
Funding rounds
- Series A
- $16M2024-02-05, Company stated
- Round, 2024
- $28.9M2024-02-02, SEC form D sold, 98 investors
- Round, 2019
- $3.6M2019-11-01, SEC form D sold, 22 investors
- Round, 2018
- $11.3K2018-07-13, SEC form D sold, 1 investor
- Round, 2018
- $12.2K2018-04-27, SEC form D sold, 1 investor
- Round, 2018
- $370K2018-02-16, SEC form D sold, 4 investors
Products
- Other
- vMap
Loading relationship preview